Ocugen (OCGN) Interest & Investment Income (2017 - 2026)
Ocugen (OCGN) posted Interest & Investment Income of $100000.0 for Q1 2026, down 65.87% on a QoQ basis from $293000.0 in Q4 2025, and down 66.67% year-over-year from $300000.0 in Q1 2025.
Ocugen (OCGN) Interest & Investment Income (2017 - 2026) Analysis & Trends
Ocugen's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 66.67% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $900000.0 (down 18.55% YoY) and the FY2025 annual result came in at $922000.0, down 29.08% from the prior year.
- Interest & Investment Income was $100000.0 for Q1 2026 at Ocugen, down from $293000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $500000.0 in Q4 2024 and bottomed at $100000.0 in Q1 2026.
- A 3-year average of $283333.3 and a median of $296500.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income plunged 31.0% — and 2026, when it sank 66.67%.
- Ocugen's Interest & Investment Income stood at $500000.0 in 2024, then tumbled by 41.4% to $293000.0 in 2025, then slumped by 65.87% to $100000.0 in 2026.
- Business Quant data shows OCGN's Interest & Investment Income at $100000.0 in Q1 2026, $293000.0 in Q4 2025, and $207000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | 1,065.00 |
| Mar 31, 2020 | 119.00 |
| Dec 31, 2019 | 107.00 |
| Sep 30, 2019 | 136.00 |
| Jun 30, 2019 | 377.00 |
| Mar 31, 2019 | 594.00 |
| Dec 31, 2018 | 1,820.00 |
| Sep 30, 2018 | 3,762.00 |
| Sep 30, 2017 | 1,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | -6,000.00 |